ARCH Venture Management, LLC
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| RAPPORT THERAPEUTICS INC.(RAPP) | 3,728,738 | 3,728,738 | 0 | 42,433,038 | 110,743,519 | 22.49% | +68,310,481 |
| MAZE THERAPEUTICS INC.(MAZE) | 4,120,053 | 4,120,053 | 0 | 50,594,251 | 106,832,974 | 21.70% | +56,238,723 |
| BEAM THERAPEUTICS INC.(BEAM) | 4,540,132 | 4,540,132 | 0 | 77,227,645 | 110,189,004 | 22.38% | +32,961,359 |
| LYELL IMMUNOPHARMA INC. | 1,820,634 | 2,759,072 | +938,438 | 16,112,611 | 44,807,329 | 9.10% | +28,694,718 |
| GOSSAMER BIO INC. | 8,055,916 | 8,055,916 | 0 | 9,908,777 | 21,187,059 | 4.30% | +11,278,282 |
| ERASCA INC.(ERAS) | 11,055,554 | 11,055,554 | 0 | 14,095,831 | 24,101,108 | 4.89% | +10,005,277 |
| VIR BIOTECHNOLOGY INC.(VIR) | 12,916,663 | 12,916,663 | 0 | 65,099,982 | 73,754,146 | 14.98% | +8,654,164 |
| Q32 BIO INC. | 320,482 | 320,482 | 0 | 477,518 | 634,554 | 0.13% | +157,036 |
| CERO THERAPEUTICS HOLDINGS INC. | 22,389 | 22,389 | 0 | 215,606 | 113,960 | 0.02% | -101,646 |
| UNITY BIOTECHNOLOGY INC. | 1,004,817 | 0 | -1,004,817 | 385,950 | 0 | — | -385,950 |
| VERVE THERAPEUTICS INC. | 2,008,809 | 0 | -2,008,809 | 22,558,925 | 0 | — | -22,558,925 |